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Mononuclear phagocytes, including monocytes,
macrophages, and dendritic cells, contribute to
tissue integrity as well as to innate and adaptive
immune defense. Emerging evidence for labor divi-
sion indicates that manipulation of these cells could
bear therapeutic potential. However, specific onto-
genies of individual populations and the overall func-
tional organization of this cellular network are not
well defined. Here we report a fate-mapping study
of the murine monocyte and macrophage compart-
ment taking advantage of constitutive and condi-
tional CX3CR1 promoter-driven Cre recombinase
expression. We have demonstrated that major
tissue-resident macrophage populations, including
liver Kupffer cells and lung alveolar, splenic, and peri-
toneal macrophages, are established prior to birth
and maintain themselves subsequently during adult-
hood independent of replenishment by blood
monocytes. Furthermore, we have established that
short-lived Ly6C+ monocytes constitute obligatory
steady-state precursors of blood-resident Ly6C
cells and that the abundance of Ly6C+ blood mono-
cytes dynamically controls the circulation lifespan
of their progeny.
INTRODUCTION
The mononuclear phagocyte system (van Furth et al., 1972)
today comprises monocytes, macrophages, and dendritic cells
(DCs), as well as their respective committed bone marrow
(BM)-resident progenitors (Geissmann et al., 2010). Collectively,these cells play central roles in the maintenance of tissue integ-
rity during development and its restoration after injury, as well as
the initiation and resolution of innate and adaptive immunity.
Historically, mononuclear phagocyte subpopulations have
been defined according to anatomic location and surfacemarker
profiles. More recently, this definition has been extended to
comprise dependence of subpopulations on specific growth
and transcription factors (Hashimoto et al., 2011; Lawrence
and Natoli, 2011), subset-specific gene expression signatures
(Robbins et al., 2008), and distinct ontogenies (Geissmann
et al., 2010).
A major breakthrough in defining mononuclear phagocyte
development in the adult organismwas the identification of a clo-
notypic BM-resident founder cell, termed macrophage-DC
precursor (MDP), that gives rise to peripheral mononuclear
phagocytes while having lost granulocyte potential (Fogg et al.,
2006). MDPs differentiate within the BM into monocytes (Varol
et al., 2007) and dedicated DC precursors, the pre-DCs (Liu
et al., 2009). Both of these cell types are subsequently released
into the circulation to allow repopulation of peripheral tissue
macrophages and classical Fms-like tyrosine kinase 3 ligand
(Flt3L)-dependent DCs, respectively. The MDP-pre-DC route is
critical to ensure the constant replenishment of the ephemeral
DC compartment. The relative importance of local proliferation
versus recruitment frommonocytes in the maintenance of tissue
macrophage homeostasis has been debated since the original
definition of the mononuclear phagocyte system (Hume, 2006;
Hume et al., 2002). The original studies of Kupffer cell turnover
in the liver, for example, concluded that very few resident macro-
phages are actively in cycle (Crofton et al., 1978). This prolifera-
tion is ablated by glucocorticoids, which also removes blood
monocytes. The authors concluded that the proliferating cells
were monocyte derived. That conclusion was, however, under-
mined by later evidence that glucocorticoids oppose growth
factor activity, including the macrophage growth factor CSF-1
(Hume and Gordon, 1984).Immunity 38, 79–91, January 24, 2013 ª2013 Elsevier Inc. 79
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Macrophage and Monocyte Fate MappingIn certain situations, such as helminth-associated T helper 2
cell milieus, expansion of local macrophages can rely solely on
proliferation of tissue-resident macrophages exclusive of mono-
cyte influx (Jenkins et al., 2011). Under inflammatory conditions,
resident macrophages are complemented by recruited mono-
cytes that differentiate in situ into macrophages. However,
when analyzed, the contribution of these infiltrating cells was
found to be transient (Ajami et al., 2011; Leuschner et al.,
2012), whereas resident macrophages bring about the resolution
of the inflammatory response and restore macrophage homeo-
stasis (Davies et al., 2011).
Myeloid cells, including mononuclear phagocytes, are known
to arise from two successive hematopoetic waves, referred to as
‘‘primitive’’ and ‘‘definitive’’ (Orkin and Zon, 2008). As best exem-
plified for the brain microglia (Alliot et al., 1999; Ginhoux et al.,
2010), mononuclear phagocytes can be generated during devel-
opment from primitive macrophages generated in the yolk
sac, an extraembryonic tissue. Once established, microglia cells
maintain themselves throughout adult life by virtue of longevity
and limited self-renewal without input from definitive hematopo-
esis (Ajami et al., 2007; Ginhoux et al., 2010; Mildner et al., 2007).
Geissmann and coworkers recently provided evidence of the
existence of a macrophage lineage that is independent of the
transcription factor myb (Schulz et al., 2012). In addition to
microglia, autonomy from definitive hematopoesis was shown
for F4/80hiCD11bint tissue macrophage populations, including
Kupffer and Langerhans’ cells.
The chemokine receptor CX3CR1 is widely expressed in the
mononuclear phagocyte system. Indeed, mice harboring a
GFP reporter in the CX3CR1 locus (Jung et al., 2000) have
been instrumental in identifying and defining MDPs (Fogg
et al., 2006), pre-DCs (Liu et al., 2009), and tissue-resident
mononuclear phagocyte populations (Bar-On et al., 2010; Lewis
et al., 2011; Niess et al., 2005; Varol et al., 2009). Moreover,
discrete expression of CX3CR1/GFP in Cx3cr1
gfp animals led
to the identification of two monocyte subsets in mice, character-
ized as CX3CR1
intLy6C+ and CX3CR1
hiLy6C cells (Geissmann
et al., 2003; Palframan et al., 2001), corroborating earlier studies
on human blood (Passlick et al., 1989). CX3CR1
intLy6C+ mono-
cytes are the correlate of human CD14+CD16+ and CD14+
CD16monocytes (Cros et al., 2010) and poised to traffic to sites
of infection and inflammation (Geissmann et al., 2003; Serbina
et al., 2008). CX3CR1
hiLy6C ‘‘patrolling’’ monocytes—the
correlate of human CD14loCD16+ cells (Cros et al., 2010)—
have been shown to adhere and crawl along the luminal surface
of endothelial cells (Auffray et al., 2007). In the absence of inflam-
mation, CX3CR1
intLy6C+ monocytes can return to the BM and
differentiate into CX3CR1
hiLy6C cells (Varol et al., 2007).
However, it is unclear whether the generation of CX3CR1
hiLy6C
monocytes requires CX3CR1
intLy6C+ monocytes as obligatory
intermediate or whether CX3CR1
hiLy6C monocytes can—like
CX3CR1
intLy6C+ monocytes (Varol et al., 2007)—also originate
directly fromMDPs. Moreover, if alternative pathways exist, their
relative contribution to the steady-state generation ofmonocytes
remains unclear.
Here, we report a fate mapping study of the murine mononu-
clear phagocyte compartment by using mice that harbor genes
encoding conditional or constitutive active Cre recombinase in
their CX3CR1 loci. We have demonstrated that tissue-resident80 Immunity 38, 79–91, January 24, 2013 ª2013 Elsevier Inc.macrophage populations, including peritoneal, splenic, and
lung macrophages, as well as liver Kupffer cells, are established
prior to birth and in adult steady state disconnected from
monocyte input. Side-by-side comparison of Cx3cr1cre and
Cx3cr1creER mice crossed to reporter animals, as well as
Cx3cr1gfp mice, combined with bromodeoxyuridine (BrdU)-
pulsing experiments, adoptive transfers, and the analysis of
Ccr2-deficient mixed BM chimeras, provided critical insights
into monocyte dynamics. Specifically, we have established
that CX3CR1
intLy6C+ monocytes form in steady state a short-
lived obligatory precursor intermediate for the generation of
Ly6C monocytes and, presumably as CSF-1 sink, dynamically
control the lifespan of their progeny.
RESULTS
Dual Origins of Resident Macrophages
To exploit the pronounced activity of the CX3CR1 promoter for
the study of the mononuclear phagocyte system, we manipu-
lated the murine CX3CR1 loci to harbor Cre recombinase genes.
Specifically, we replaced the Cx3cr1 gene with genes encoding
either cre recombinase or a cre recombinase fusion to a mutant
estrogen ligand-binding domain that requires the presence of
the estrogen antagonist tamoxifen for activity (CreERT2)
(Metzger et al., 1995), yielding Cx3cr1cre and Cx3cr1creER mice
(Figure 1A).
Recent studies have highlighted the differential origins of
discrete peripheral macrophage and DC compartments in adult
mice (Geissmann et al., 2010). Given the broad expression of the
Cx3cr1 gene within the mononuclear phagocyte system, we
decided to perform a side-by-side comparison of the reporter
gene activation patterns inCx3cr1gfp,Cx3cr1cre, andCx3cr1creER
mice, the latter crossed to R26-yfp reporter animals (Figure S1
available online; Srinivas et al., 2001). Macrophage populations
from Cx3cr1gfp and Cx3cr1cre:R26-yfp mice fell into two cate-
gories. Cells, such as microglia and intestinal and renal macro-
phages, express the CX3CR1 chemokine receptor (Jung et al.,
2000; Niess et al., 2005; Soos et al., 2006) and hence are
found labeled in both Cx3cr1gfp and Cx3cr1cre:R26-yfp mice
(Figure 1B). A second group of cells ceased to express the
chemokine receptor but obviously originated from CX3CR1
+
precursors, indicated by the absence and presence of label in
Cx3cr1gfp and Cx3cr1cre:R26-yfp mice, respectively. This
included peritoneal macrophages, liver Kupffer cells, and splenic
and lung macrophages as well as epidermal Langerhans’ cells
(Figure 1C). Coexistence of the respective CX3CR1-positive cells
and CX3CR1-negative cells that acquired the label during their
past in steady-state tissues was confirmed by the histological
examination of triple transgenic Cx3cr1gfp:Cx3cr1cre:R26-rfp
mice, which harbored differentially labeled cells, as exemplified
for RFP-positive CD11bintF4/80hi Kupffer cells and GFP-positive
CD11bhiF4/80int perivascular macrophages in the liver (Fig-
ure 2Ai). Moreover, the notion that CX3CR1-negative
CD11bintF4/80hi Kupffer cells derive from cells that previously
expressed CX3CR1 was corroborated by the fact that
CD11bintF4/80hi Kupffer cells were found to be GFP+ in fetal
livers but GFP in adult livers of Cx3cr1gfp mice (Figure 2Aii).
Because in Cx3cr1cre:R26-yfp mice Cre recombinase is con-
stitutively active, CX3CR1
+ precursors establish the label in
Figure 1. Reporter Gene Expression Profile
of Macrophage Populations in Cx3cr1gfp/+,
Cx3cr1cre/+:R26-yfp, andTamoxifen-Treated
Cx3cr1creER/+:R26-yfpMice
(A) Schematic of modified Cx3cr1 loci. The
Cx3cr1cre and Cx3cr1creER mice were crossed to
R26-yfp mice, in which irreversible induction of
YFP expression is induced upon Cre recombinase
expression and activation, respectively.
(B and C) Flow cytometric analysis of CX3CR1
+
(B) and CX3CR1
 (C) mononuclear phagocyte
populations of Cx3cr1gfp/+, Cx3cr1cre/+:R26-yfp,
and Cx3cr1creER/+:R26-yfp mice. Cx3cr1creER/+:
R26-yfp mice were treated for 4 weeks with
tamoxifen prior to analysis. Results are represen-
tative of six mice per group.
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prenatal development, or represent adult precursors, such as
MDPs or monocytes (Fogg et al., 2006; Jung et al., 2000). To
distinguish between these two scenarios, we took advantage
of Cx3cr1creER:R26-yfp mice, in which Cre activity can be regu-
lated by drug administration and hence induced after birth.
One month of continuous tamoxifen exposure of adult animals
resulted in the efficient reporter gene expression in CX3CR1
+
resident macrophages and microglia of Cx3cr1creER:R26-yfp
mice (Figure 1B). Moreover, it yielded substantial excision of
the LoxP-flanked STOP cassette from the R26-STOP-YFP loci,
and hence YFP expression, in the monocyte compartment (seeImmunity 38, 79–9below). However, no reporter gene
expression was detected in the CX3CR1

macrophage populations of the tamox-
ifen-treated Cx3cr1creER:R26-yfp mice,
signifying that no monocytes had entered
the pool.
To formally establish that descendants
of monocytes from tamoxifen-treated
animals can be detectable according to
reporter gene expression after an ex-
tended period of time in a tissue context,
we resorted to an adoptive transfer
strategy focusing on intestinal resident
macrophages that we previously estab-
lished to be Ly6C+ monocyte derived
(Varol et al., 2009). Specifically, Ly6C+
YFP BM monocytes isolated from
tamoxifen-treated mice were adoptively
transferred into diphtheria toxin-treated
CD11c-DTR/WT BM chimeras (Varol
et al., 2009). As seen in Figure 2B, grafted
cells gave rise to YFP+ lamina propria
macrophages. Notably, because the
recipients were not treated with tamox-
ifen, the rearrangement of the R26-
STOP-YFP loci must have occurred in
the donor animals. The fact that mono-
cyte-derived cells could be detected
in tamoxifen-treated adult Cx3cr1creER:
R26-yfp mice according to their reporterexpression was further corroborated by analyzing mice chal-
lenged intraperitoneally with thioglycollate, which led to the
appearance of RFP+ cells in the peritoneal cavities 72 hr after
treatment (Figure 2C). Interestingly, after the resolution of this
response, cells derived from the monocyte infiltrate persisted
for up to 2 months after challenge. This was associated with
a phenotypic shift to MHCIIloF4/80hi cells, suggesting the inte-
gration of the monocyte-derived cells into the resident macro-
phage pool (Figure 2C).
Collectively, the absence of label in resident CX3CR1
macro-
phage populations of tamoxifen-treated Cx3cr1creER:R26-yfp
mice establishes that there is no on-going steady-state1, January 24, 2013 ª2013 Elsevier Inc. 81
Figure 2. Dual Origins of Macrophages
(A) (i) Flow cytometric and histological analysis of
liversobtained fromCx3cr1cre/+:R26-rfp:Cx3cr1gfp/+
mice. In thesemiceGFP expression acts as a direct
reporter for CX3CR1 expression, whereas RFP
expression is controlled by Cre recombinase. (ii)
Analysis of fetal and adult liver Kupffer cells of
Cx3cr1gfp/+ mice.
(B) Flow cytometric analysis of the intestinal
lamina propria of DTx-treated Cd11c-dtr mice
that received 7 days earlier a Ly6C+YFP mono-
cyte graft isolated from tamoxifen-treated
Cx3cr1creER/+:R26-yfp mice. Results are repre-
sentative of two experiments involving three mice
per group.
(C) Flow cytometric analysis of peritoneal lavages
of Cx3cr1creER/+:R26-rfp mice administered a
single tamoxifen gavage (5 mg) 1 day after an
intraperitoneal thioglycollate injection. Rightmost
graph shows phenotypic shift of monocyte-
derived cells between 3 weeks and 8 weeks.
Results are representative of two independent
experiments involving three mice per group.
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and lung macrophages and that these cells derive prenatally
originating either independent from the yolk sac or fetal liver cells
and subsequently maintaining themselves through longevity and
limited self-renewal.
Characterization of Myeloid Precursors and Monocytes
in Cx3cr1cre:R26-yfp and Cx3cr1creER:R26-yfp Mice
CX3CR1 chemokine receptor expression commences with the
first dedicated mononuclear phagocyte precursor, the MDP,
and expression is subsequently maintained in DC-committed
precursors (CDPs, pre-DCs) and monocytes (Fogg et al., 2006;
Liu et al., 2009; Onai et al., 2007). All these cell populations
are consequently homogeneously marked by reporter gene
expression in Cx3cr1gfp mice (Figure 3A). Interestingly, however,
reporter gene expression was absent from MDPs of Cx3cr1cre:82 Immunity 38, 79–91, January 24, 2013 ª2013 Elsevier Inc.R26-yfp mice; rather, YFP+ cells first
appeared at the CDP and Ly6C+ mono-
cyte stage (Figure 3). This delay of YFP
expression compared to Cx3cr1gfp mice
may be due to the time restraint imposed
by the required rearrangement for STOP
cassette excision prior to reporter gene
expression in Cx3cr1cre:R26-yfp animals.
In Cx3cr1creER:R26-yfp mice, where
reporter activation requires the nuclear
translocation of the CreER protein prior
to rearrangement, YFP expression was
found to be even further restricted.
Thus, in tamoxifen-treated Cx3cr1creER:
R26-yfp mice, reporter gene expression
was absent from CDPs and Ly6C+ mono-
cytes (Figure 3B). Only Ly6C mono-
cytes—and only a fraction of them—
expressed YFP even after extended
tamoxifen treatment (Figure 3B). Thedifferential appearance of the YFP label in Ly6C+ and Ly6C
monocyte subsets indicated distinct temporal requirements
for their creation, supporting the notion of their sequential gener-
ation (Sunderko¨tter et al., 2004; Varol et al., 2007; Yrlid et al.,
2006). Notably, key surface markers recently reported for the
two monocytes subsets (Ingersoll et al., 2010) displayed gradual
alterations between Ly6C+YFP, Ly6CYFP, and Ly6CYFP+
cells in Cx3cr1creER:R26-yfp mice (Figure S2A). Furthermore,
comparison of expression of these markers by Cx3cr1cre:
R26-yfpmonocyte subsets also demonstrated gradual changes
from Ly6C+YFP to Ly6C+YFP+ and Ly6CYFP+ cells (Fig-
ure S2B). Taken together, reporter gene expression kinetics in
Cx3cr1cre andCx3cr1creER:R26-yfpmiceand thegradual acquisi-
tion of maturation markers in the monocyte subsets support the
notion that Ly6C+monocytes differentiate into Ly6Cmonocytes
in steady state.
Figure 3. Reporter Gene Expression Profile
of Mononuclear Phagocyte Precursors and
Circulating Monocytes
(A and B) Flow cytometric analysis of different
mononuclear phagocyte populations: precursors
(A) and blood monocytes (B) obtained from
Cx3cr1gfp/+,Cx3cr1cre/+:R26-yfp, andCx3cr1creER/+:
R26-yfp mice. Cx3cr1creER/+:R26-yfp mice were
treated for 4 weeks with tamoxifen prior to analysis.
Results are representative of four to six mice per
group.
(C) Bar graph summarizing frequencies of GFP or
YFP+ cells in indicated mononuclear phagocyte
populations of Cx3cr1gfp/+, Cx3cr1cre/+:R26-yfp,
and Cx3cr1creER/+:R26-yfpmice. Mean ± SEM are
performed with four to six mice per group.
See also Figures S1 and S2.
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Independently in BM and Blood
With the definition of MDPs as in vivo monocyte precursors
(Varol et al., 2007), the question arose whether these cells give
rise to both CX3CR1
intLy6C+ and CX3CR1
hiLy6C monocytes
or whether the two monocyte subsets are part of a develop-
mental sequence (Sunderko¨tter et al., 2004; Varol et al., 2007;
Yrlid et al., 2006). Although adoptively transferred Ly6C+
CX3CR1
int monocytes isolated from BM can give rise to Ly6C
CX3CR1
hi monocytes in recipient mice (Varol et al., 2007), these
grafts could have arguably been contaminated with immature
BM precursors. To exclude this possibility, we isolated CX3
CR1GFP/+Ly6C+ monocytes from the splenic reservoir (Swirski
et al., 2009) and grafted them into congenic WT mice (Fig-Immunity 38, 79–9ure S3A). Recipients were sacrificed at
various time points after adoptive transfer
and subjected to flow cytometry analysis.
One day after transfer, grafted cells were
detectable in recipient blood, BM, and
spleen as Ly6C+CX3CR1/GFP
int cells
(Figure S3B). However, corroborating
our earlier study (Varol et al., 2007), by
day 3 grafted splenic Ly6C+ monocytes
had quantitatively differentiated into
Ly6CCX3CR1/GFP
hi cells.
Next, we compared the differentiation
potential of Ly6C+YFP and Ly6C+YFP+
monocytes of Cx3cr1cre:R26-yfp mice.
Isolated monocyte subsets were grafted
into congenic WT recipient mice. Analysis
over a 3 day period revealed a number of
sequential steps required for Ly6C+
monocytes toconvert. Ly6C+YFPmono-
cytes transformed from being YFP nega-
tive to cells expressing the YFP reporter
prior to converting into Ly6Cmonocytes,
authenticating the notion that Ly6C+
monocytes are the precursors of Ly6C
monocytes and our earlier assumption
that acquisition of the YFP label bymono-
cytes is a matter of time (Figure S4).To further investigate the interrelation of blood monocytes and
determine their turnover rates, we resorted to a 5-bromo-20-
deoxyuridine (BrdU) pulsing regime. Specifically, mice were
dosed with three intraperitoneal (i.p.) injections of 2 mg BrdU
(3 hr apart) and subsequently monitored over a 5 day period
for the presence of the thymidine analog in the genome of the
monocyte subsets. This low dose of BrdU is unlikely to be mito-
genic (Takizawa et al., 2011). Because only a minor subset of
monocytic cells is in cell cycle, BrdU is expected to be incorpo-
rated into dividing monocyte precursors, such as MDPs. One
day after the first BrdU injection, all circulating Ly6C+monocytes
were BrdU positive (Figure 4A). In contrast, no Ly6C blood
monocytes had incorporated label by day 1, indicating that these
cells are not recently generated from a dividing precursor. The1, January 24, 2013 ª2013 Elsevier Inc. 83
Figure 4. Monocyte Subset Dynamics
(A and B) Flow cytometric analysis of Ly6C+ and
Ly6C blood monocyte subsets pulsed three
times with 2 mg BrdU 3 hr apart and monitored
over 5 days. (B) Mice were treated with CCR2
antibody MC21 and BrdU incorporation by Ly6C
blood monocyte was analyzed.
(C) Analysis of time course of BrdU incorpora-
tion of Ly6C+ and Ly6C monocytes in blood
(red) and BM (blue) after a single 2 mg pulse of
BrdU; BrdU incorporation by monocytes in mice
treated with the MC21 antibody (green). Mean ±
SEM are performed with three to four mice per
group.
See also Figures S2–S6.
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increased to around one-third by day 5 (Figure 4A), whereas
the Ly6C+ monocytes lost the label by day 5. Fitting an exponen-
tial trendline from day 2 (i.e., the peak of BrdU label) to day 5, we
calculated the steady-state half-life of the Ly6C+ blood
monocytes to be 0.843 days (20 hr) (r2 = 0.932). The sequential
acquisition of the BrdU label by the blood monocyte subsets
suggested that it was incorporated into monocyte precursors
that differentiated into Ly6C+ monocytes and subsequently
moved with time to Ly6C monocytes. To corroborate this
assumption, we took advantage of a cell ablation strategy target-
ing Ly6C+ monocytes based on the injection of the CCR2 anti-
body MC21 (Bru¨hl et al., 2007). MC21 treatment of BrdU-pulsed
mice on day 1 efficiently ablated CCR2+Ly6C+ monocytes and
spared as reported CCR2Ly6C cells (Figure 4B). Interesting
though and supporting the notion of a precursor/product rela-84 Immunity 38, 79–91, January 24, 2013 ª2013 Elsevier Inc.tionship of the two monocyte subsets,
removal of BrdU-labeled Ly6C+ mono-
cytes also prevented accumulation of
the BrdU label in the Ly6C monocyte
population (Figure 4B).
To refine our analysis and extend it to
monocytes residing in BM, C57BL/6
animals were injected with a single dose
of BrdU (2 mg) (Figure 4C). Analysis of
blood monocytes confirmed the sequen-
tial appearance of the BrdU label in Ly6C+
and Ly6C monocytes, respectively.
Ly6C+ monocytes in the BMwere labeled
before Ly6C+ blood monocytes, consis-
tent with their generation from MDPs in
the BM (Varol et al., 2007). BM-resident
Ly6C cells were found to incorporate
BrdU well before the blood Ly6C mono-
cytes, though still delayed when com-
pared to BM Ly6C+ monocytes. This
suggests that Ly6C BM monocytes are
generated in the BM and Ly6C blood
monocytes are generated in the blood.
In line with this notion, MC21 treatment
that ablates Ly6C+ blood but not Ly6C+
BM monocytes did not impair labeling of
BM Ly6C monocytes (Figure 4C).
Collectively, these data establish that Ly6C+ monocytes are
precursors of Ly6C cells. Moreover, the limited acquisition of
BrdU label in the Ly6C monocytes supports the earlier notion
based on adoptive transfer experiments (Geissmann et al.,
2003) that these cells have an extended circulation half life as
compared to Ly6C+monocytes. Finally, differential label acquisi-
tion by Ly6C BM and blood monocytes suggest that these
compartments are established, and in steady state maintained,
independent of each other.
Ly6C+ Blood Monocytes Are Obligatory Precursors
of Steady-State Ly6C– Monocytes
Among monocytes, membrane expression of the chemokine
receptor CCR2 is restricted to Ly6C+ cells and a prerequisite
for these cells to exit from the BM (Serbina and Pamer,
2006; Shi et al., 2011). Accordingly, Ly6C+ monocytes are
Figure 5. Impaired BM Exit of Ly6C+ Blood
Monocyte Affects the Ly6C– Cell Compart-
ment
(A) Flow cytometric analysis of mixed Ccr2/:
Cx3cr1gfp/+ (CD45.2)/Ccr2+/+:Cx3cr1gfp/+ (CD45.1)/
WT BM chimeras. Distribution of cells within the
mononuclear compartment were analyzed for
percentage of CD45.2+ cells. Cell definitions for
gating: MP, LinCD135+CD115CD117+; MDP, Lin
CD135+CD115+CD117+; CDP, LinCD135+CD115+
CD117; pre-DC, LinCD11cintMHCIICD135+
CD172aCX3CR1
+; monocyte, CD11b+ CD115+.
Results are representative of six analyzed mice.
(B) Analysis of mixed Ccr2/:Cx3cr1gfp/+
(cd45.2)/Ccr2+/+:Cx3cr1gfp/+ (CD45.1) / WT BM
chimeras. Representative result of two experi-
ments involving three to five mice per group.
See also Figures S3–S6.
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CCR2-deficient mice (Serbina and Pamer, 2006). If Ly6C+ blood
monocytes are precursors of Ly6C monocytes, the impairment
of Ly6C+ cell compartment would be expected to impinge on
Ly6C monocytes. To probe this point more rigorously, we
analyzed monocyte subset distributions in a competitive
setting by generating mixed chimeras, with BM isolated
from CCR2-proficient (CD45.1) and CCR2-deficient (CD45.2)
Cx3cr1gfp/+ mice. Analysis of the BM of the respective chimeras
8 weeks after irradiation revealed that the two genotypes
were equally prevalent among MPs and MDPs, as well as DC
precursors (CDPs and pre-DCs) (Figures 5A and 5B). BM-
resident CCR2mutant Ly6C+monocytes were found to accumu-
late, presumably as a result of their impaired BM exit (Serbina
and Pamer, 2006), whereas BM-resident mutant Ly6C mono-Immunity 38, 79–9cytes were moderately dominated by
CD45.1+ WT cells (Figure 5B). As ex-
pected from the reported phenotype of
Ccr2/ mice (Serbina and Pamer,
2006), in the blood Ly6C+Ccr2/ mono-
cytes (CD45.2) were outcompeted
by their CD45.1+ WT counterpart (Fig-
ure 5A), but CCR2 deficiency also
compromised the Ly6C blood mono-
cytes, with mutant cells underrepre-
sented in both compartments (Figures
5A and 5B). The competitive disadvan-
tage of both Ly6C+ and Ly6C CCR2-
deficient monocytes was also evident in
the spleen (Figure 5B), although it was
less pronounced for Ly6C+ cells, which
after having entered the splenic pool
might be trapped because of impaired
mobilization.
Collectively, this establishes that the
generation of Ly6CCX3CR1
hi mono-
cytes in steady state critically depends
on CCR2-proficient Ly6C+CX3CR1
int
monocytes as immediate precursors.
Moreover, in order to serve as Ly6CCX3CR1
hi monocyte progeny, these cells have to exit from the
BM to the circulation.
Ly6C+ BloodMonocytes Negatively Control the Lifespan
of Ly6C– Monocytes
The fact that Ccr2/ mice harbor circulating Ly6CCX3CR1
hi
monocytes despite their impaired Ly6C+ monocyte compart-
ment (Qu et al., 2004) seemingly contradicts the notion that the
latter cells require Ly6C+ monocytes as precursors. Indeed,
analysis of the frequencies of the two monocyte subsets in
Ccr2/Cx3cr1gfp mice confirmed the presence of a sizable
Ly6CCX3CR1
hi monocyte population, albeit drastically reduced
as compared to Ccr2+/+:Cx3cr1gfp littermates (Figure 6A). Inter-
estingly, Ly6C bloodmonocytes ofCcr2/mice had downmo-
dulated their receptors for themacrophage growth factor CSF-1,1, January 24, 2013 ª2013 Elsevier Inc. 85
Figure 6. Prevalence of Ly6C+ Blood Mono-
cytes Determines the Circulation Half-Life
of Ly6C– Blood Cells
(A) Analysis of Ly6C+ and Ly6C blood mono-
cyte subsets of Ccr2+/+Cx3cr1gfp/+ and Ccr2/
Cx3cr1gfp/+ mice. Mean ± SEM are performed with
four to six mice per group.
(B) Mean fluorescent intensities of CD115
expression on Ly6C monocytes analyzed in (A).
Mean ± SEM are performed with four to six mice
each.
(C) Flow cytometric analysis of blood of
Cx3cr1creER/+:R26-yfp mice treated by tamoxifen
gavage to induce excision of the STOP cassette
from R26-YFP loci. Ly6C blood monocytes were
analyzed over a 2 week period for reporter gene
expression. Mice were left untreated or treated
with the CCR2 antibody MC21. Representative
result of two experiments involving three mice per
group.
(D) Mean fluorescent intensities of CD115
expression on Ly6CYFP+ monocytes analyzed in
(C). Mean ± SEM are performed with three mice
per group.
(E) Mean fluorescent intensities of CD115
expression on Ly6C monocytes of mice that
received an injection of recombinant CSF-1.
Mean ± SEM are performed with three mice each.
(F) Flow cytometric analysis of blood of tamoxifen-
treated Cx3cr1creER/+:R26-yfp mice. Ly6C blood
monocytes were analyzed over a 2 week period
for reporter gene expression. Mice were left
untreated, treated with the CCR2 antibody, or
treated with a combination of MC21 and anti-
CSF-1 R. Table summarizes half-lives of Ly6C
blood monocytes in the time window from 4 to
10 days, as determined by exponential trendline
fitting.
See also Figures S5 and S6.
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late that in Ccr2/ mice, Ly6CCX3CR1
hi monocytes might
compensate for the diminished replenishment from Ly6C+
monocytes by extending their lifespan.
To directly investigate this possibility, we took advantage of
our fate mapping system. A single 5 mg tamoxifen gavage of
Cx3cr1creER:R26-yfp mice induced in their CX3CR1
+ cells the
nuclear translocation of Cre recombinase and rearrangement
of the YFP reporter locus, resulting in a discrete label of Ly6C
monocytes peaking by day 4 after gavage (Figure 6C). This label
disappeared with time, and exponential trendline fitting from day
4 onward yielded a calculated steady-state half-life of Ly6C
blood monocytes of 2.2 days (r2 = 0.996). If this half-life is criti-
cally determined by input from CCR2-expressing Ly6C+ mono-
cytes, then ablation of the latter via the anti-CCR2 regimen
should affect it. Indeed, as seen in Figure 6C, MC21 treatment
resulted in persistence of YFP-labeled Ly6C monocytes in
tamoxifen-treated Cx3cr1creER:R26-yfp mice, extending their
half-life from 2.2 days to 11 days (r2 = 0.992). Once Ly6C+ mono-
cytes were restored, after cessation of MC21 treatment, Ly6C86 Immunity 38, 79–91, January 24, 2013 ª2013 Elsevier Inc.cells regained their steady-state half-life and the population
hence lost its YFP label. The depletion of CCR2-expressing
Ly6C+ monocytes was associated with a substantial downmo-
dulation of detectable CD115 (CSF-1 receptor) on the Ly6C
monocytes, reminiscent of the situation in Ccr2/ mice (Fig-
ure 6B), which was restored after MC21 withdrawal (Figure 6D).
Downmodulation of the CSF-1 receptor from the cell surface
could be a reflection of engagement by its ligand and indeed
administration of recombinant CSF-1 provided direct evidence
that this can occur (Figure 6E). Because myeloid cells them-
selves control the circulating availability of CSF-1 (Bartocci
et al., 1987; Tushinski et al., 1982), depletion of CSF-1R-
expressing Ly6C+ monocytes in Ccr2/ mice or MC21-treated
animals could potentially alter the availability of the factor.
Although a blocking antibody against the receptor causes
a substantial increase in circulating CSF-1 (MacDonald et al.,
2010), we were not able to detect such an increase in the
depleted animals (Figure S5). Nevertheless, to examine the
function of CSF-1 in the extension of the circulation half-life of
Ly6C monocytes, we tested the impact of CSF-1 receptor
Immunity
Macrophage and Monocyte Fate Mappingneutralization by using an antibody shown previously to
ablate these cells in a time-dependent manner (MacDonald
et al., 2010). Specifically, we coadministered tamoxifen-treated
Cx3cr1creER:R26-yfp mice with the MC21 regimen and CSF1R
antibody. Interestingly and in support of a role of CSF-1 in the
phenomenon, this protocol partially prevented the half-life
extension of the YFP-labeled Ly6C cells after depletion of
Ly6C+ monocytes (Figure 6F).
DISCUSSION
Here, we have reported a fate mapping analysis of the murine
macrophage and monocyte compartment by taking advantage
of mice that harbor genes encoding a GFP reporter or Cre re-
combinases in their CX3CR1 loci. We have demonstrated that
the major tissue macrophage populations in the liver, spleen,
lung, and peritoneal cavity are established prenatally during
mouse development and provided definitive support for the
view that in the healthy adult organism, tissue macrophages
can be maintained independent of monocyte input. In addition,
we have provided evidence that CX3CR1
intLy6C+ monocytes
are, in steady state, an obligatory intermediate for the generation
of CX3CR1
hiLy6C monocytes and via their abundance control
the circulation half-life of their progeny.
Recent studies have highlighted the existence of multiple
pathways for the generation and maintenance of distinct
mononuclear phagocyte subpopulations in the adult mouse
(Geissmann et al., 2010). Accordingly, classical short-lived
Flt3L-dependent DCs are continuously renewed by on-going
hematopoiesis in the BM that feeds the periphery with dedicated
DC precursors (Naik et al., 2007; Onai et al., 2007; Karsunky
et al., 2003; Waskow et al., 2008). The temporal tissue residence
profiles of macrophages have remained less well defined (Hume,
2006; Hume et al., 2002). Macrophages residing in the murine
intestinal lamina propria are reported to have an estimated
half-life of 3 weeks (Jaensson et al., 2008). Moreover, by using
adoptive cell transfers, we and others provided evidence that
these intestinal CX3CR1
+ macrophages are continuously replen-
ished from Ly6C+monocytes (Bogunovic et al., 2009; Varol et al.,
2009). However, the gut mucosa-associated tissue probably
represents an exception, because it is constitutively exposed
to the luminal microflora and its products, which probably cause
tonic low-grade inflammation. Other macrophage populations
such as alveolar macrophages have been reported to persist
for years (Murphy et al., 2008). Notably, however, previous
studies on macrophage half-lives have been confounded by
the fact that they involved irradiation regimens, which induce
considerable damage to the tissue analyzed. Clear distinctions
between inflammatory monocyte infiltrates and resident macro-
phages in these experimental setups might hence have been
blurred. This complication was recently clarified in a series of
studies that aimed to define the origins of brain microglia
(Ginhoux et al., 2010).
Our comparative analysis of mice carrying a GFP reporter and
conditional or constitutive active Cre recombinase genes in their
Cx3cr1 loci revealed that Kupffer cells, as well as lung, perito-
neal, and splenic macrophages, are established before birth
and remain in adulthood uncoupled from the steady-statemono-
cyte pool. Notably, our results are well in line with the recentdemonstration that epidermal Langerhans’ cells are derived
from primitive macrophages and fetal liver cells, but that in adult-
hood this compartment maintains itself independent frommono-
cyte input (Hoeffel et al., 2012). Congruent with these data,
patients with autosomal-dominant and sporadic monocytopenia
present with an unaffected Langerhans’ cell compartment
(Bigley et al., 2011). What is more, our results are consistent
with the recent evidence of the coexistence of two independent
macrophage lineages in the mouse according to their differential
dependence on the transcription factors PU.1 and c-myb
(Schulz et al., 2012).
It is tempting to speculate that the reliance on resident macro-
phage populations established before birth represents an impor-
tant design principle of tissue homeostasis ensuring robustness
of the steady state. Accordingly, challenges such as injury and
pathogen encounter will result in the recruitment of highly plastic
monocytes, which critically but transiently (Ajami et al., 2011)
contribute to inflammation and its resolution until restoration
of homeostasis. Although our study focuses on the steady
state, we have shown that an inflammatory stimulus can recruit
monocytes whose descendants can seemingly integrate into
the resident serosal, peritoneal cavity macrophage compart-
ment. Future studies will have to address whether these cells
become functionally equivalent to the resident cells and whether
this applies also to solid tissues.
Monocytes can be divided into two main subpopulations,
defined in the human as CD14hiCD16+/ and CD14loCD16hi cells
and in the mouse as Ly6C+CX3CR1
int and Ly6CCX3CR1
hi cells
(Geissmann et al., 2003; Palframan et al., 2001). Earlier studies
have provided circumstantial evidence that the monocyte
subpopulations of themouse are a differentiation series (Sunder-
ko¨tter et al., 2004; Varol et al., 2007; Yrlid et al., 2006). Here we
have reported the use of a series of complementary noninvasive
approaches to interrogate the steady-state contribution of
a Ly6C+ monocyte intermediate to the generation of Ly6C
monocytes. First, we observed distinct temporal requirements
for the creation of the two monocyte subsets with delayed
appearance of the YFP reporter label in Ly6C monocytes in
Cx3cr1cre:R26-yfp and Cx3cr1creER:R26-yfp mice, as compared
to Cx3cr1gfp mice. Second, we have shown that a BrdU pulse
label moves with time from Ly6C+ monocytes to Ly6C mono-
cytes and ablation of the former cells abolishes appearance of
the label in the latter. The data support earlier reports of an
exceedingly short circulation half-life of Ly6C+ monocytes (Liu
et al., 2007; Varol et al., 2007), that at 0.8 days (19 hr), is longer
than but comparable to that of short-lived neutrophils (11.4 hr)
(Basu et al., 2002). Finally, we have shown by using competitive
mixed chimeras that CCR2, which is critical for the BM exit of
Ly6C+ monocytes (Serbina and Pamer, 2006; Shi et al., 2011),
is also required for the generation of Ly6C monocytes. This
strongly suggests that the majority, if not all, blood Ly6Cmono-
cytes are derived from CCR2+Ly6C+ blood monocytes in the
steady state (Figure S1).
We have also demonstrated that Ly6Cmonocytes are gener-
ated independently in situ in the bone marrow. Thus, Ly6C BM
monocytes acquired the BrdU label well before the Ly6C blood
monocytes and appearance of the BrdU label was unaffected by
the MC21-mediated ablation of Ly6C+ blood monocytes. More-
over, also the differential dependence of Ly6C BM and bloodImmunity 38, 79–91, January 24, 2013 ª2013 Elsevier Inc. 87
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BrdU incorporation of the latter to the MC21 regimen, suggest
that these cells are generated in BM and blood, respectively.
It remains to be shown whether Ly6C BM monocytes arise
like Ly6C blood monocytes via a Ly6C+ intermediate or can
be generated directly from MDPs, because the MC21 treatment
spares Ly6C+ BM monocytes. The function of Ly6C blood
monocytes has been proposed to be to patrol and survey
endothelial integrity (Auffray et al., 2007). When cultured in vitro
with CSF-1 (M-CSF) or CSF-2 (GM-CSF), both Ly6C+ and
Ly6C monocytes can differentiate into macrophages and
DCs, respectively (data not shown). However, whereas Ly6C+
monocytes are established in vivo precursors of intestinal
macrophages, Ly6C monocytes fail to do so (Varol et al.,
2009). Moreover, reports demonstrating an in vivo potential
of these cells to act as resident mononuclear phagocyte pre-
cursors are scarce (Landsman and Jung, 2007; Nahrendorf
et al., 2007). Paradoxically, in humans the supposed functional
equivalent, the CD14CD16+ nonclassical monocytes, is nor-
mally much less abundant but increases in response to chronic
inflammatory stimuli (Ziegler-Heitbrock et al., 2010). In light of
our present findings, we propose that Ly6C blood monocytes
represent the homeostatic default product of short-lived Ly6C+
monocytes in the blood that surveys endothelial integrity
(Auffray et al., 2007), as terminally differentiated blood-resident
macrophages.
Our study has revealed that the lifespan of Ly6C blood
monocytes is affected by the prevalence of Ly6C+ blood
monocytes, their direct precursors. Thus, whereas these cells
display in unmanipulated steady state a half-life of 2 days, their
half-life is extended to 11 days when the Ly6C+ precursors are
ablated. Prolonged neutralization of the CSF-1 receptor has
been shown to result in the selective loss of Ly6C blood
monocytes (MacDonald et al., 2010). Conversely, ablation of
CD115+Ly6C+ blood monocytes could result in an increase of
plasma CSF-1 promoting survival of Ly6C blood monocytes.
Interestingly, CD115 amounts were found downmodulated on
Ly6C blood monocytes of CCR2/ mice. Moreover, expres-
sion of CD115 was also reduced in mice in which Ly6C+ blood
monocytes were ablated, but CD115 was rapidly restored upon
withdrawal of the MC21 treatment. Extension of the half-life in
response to the MC21 treatment was partially impaired by
concomitant neutralization of the CSF-1 receptor, suggesting
that limited CSF-1 availability in the serum is associated with
this phenomenon and that Ly6C+ monocytes constitute a sink
for this critical survival factor. Interestingly, CSF-1 has been re-
ported to induce the NOR1 (Pei et al., 2005), an orphan nuclear
receptor and member of the steroid thyroid receptor family,
which also comprises Nur77 (Nr4A) that was recently impli-
cated in the control of Ly6C monocyte survival (Hanna
et al., 2011).
Although the exact molecular pathway underlying the regula-
tion remains to be elucidated, our study establishes that Ly6C+
monocytes are not only obligatory steady-state precursors of
Ly6Cmonocytes, but also restrict the lifespan of their otherwise
long-lived progeny. Conversely, the unique ability of Ly6C
monocytes to extend their circulation half-life could be a mecha-
nism to ensure robustmaintenance of a critical Ly6C population
size, potentially required for efficient surveillance of endo-88 Immunity 38, 79–91, January 24, 2013 ª2013 Elsevier Inc.thelial integrity (Auffray et al., 2007), even under conditions
when Ly6C+ monocytes are withdrawn from their precursor
task to sites of inflammation.
Collectively, we have provided here a fate mapping study of
murine mononuclear phagocytes, focusing on macrophages
and monocytes. Our results highlight the coexistence of distinct
tissue-resident macrophage populations in the mammalian
organism, including cellular compartments that are established
during development from primitive macrophages or fetal liver
cells but remain during health independent frommonocyte input.
Within the monocyte compartment, we have established Ly6C+
blood monocytes as obligatory precursor cells of Ly6C blood
monocytes and reveal that the lifespan of these cells can be
dynamically regulated to maintain a stable Ly6C blood mono-
cyte compartment in case of Ly6C+ blood monocyte shortage.
Full appreciation of the monocyte and macrophage complexity
in the mammalian organism will require future studies exploring
the existence of distinctive molecular and functional characteris-
tics of these distinct populations that might pave the way for
rational strategies to manipulate mononuclear phagocytes for
therapeutic purposes.
EXPERIMENTAL PROCEDURES
Mice
The following 6- to 10-week-old mouse strains were used: Cx3cr1gfp/+ mice
(Jung et al., 2000), Pgk-cremice (Lallemand et al., 1998),Ccr2/mice (Boring
et al., 1997), and Ccr2/:Cx3cr1gfp/+ mice. To analyze recombinase activity
of Cx3cr1cre or Cx3cr1creER mice (for generation information, see Supple-
mental Experimental Procedures), these animals were crossed to Rosa-
26-yfp (Srinivas et al., 2001) or Rosa-26-rfp (Luche et al., 2007) reporter
mice. BM chimera animals were lethally irradiated and reconstituted with
donor BM (see Supplemental Experimental Procedures for further details).
All mice studied were on C57BL/6 background, maintained under specific-
pathogen-free conditions, and handled under protocols approved by the
Weizmann Institute Animal Care Committee (IACUC) in accordance with inter-
national guidelines.
Tamoxifen Treatment
Tamoxifen was administered either orally or subcutaneously. See Supple-
mental Experimental Procedures for further details.
Isolation of Tissue Samples
Blood, BM, and tissue samples were prepared as described previously (Yona
et al., 2010). Single-cell suspensions were then stained and subsequently
analyzed by polychromatic flow cytometry. A detailed description of tissue
mononuclear phagocyte isolation and antibody clones used throughout this
study can be found in the Supplemental Experimental Procedures.
Isolation of Monocytes for Adoptive Transfers
BM cells were harvested and mononuclear cells enriched by density gradient.
Splenic monocytes were isolated by MACS enrichment with biotinylated
CD115 antibody and streptavidin-coupled magnetic beads (Miltenyi Biotec).
Ly6Chi monocytes were identified as CD11b+CD115+ and Gr-1+, cells were
purified by high-speed cell sorting and with a FACS Aria (Becton-Dickson).
Sorted cells were resuspended and injected i.v. into congenic CD45.1 WT
mice. See Supplemental Experimental Procedures for further details.
BrdU Pulsing
Mice were treated with three injections of 2 mg BrdU (5-bromo-2-deoxyuri-
dine; BD PharMingen) i.p. 3 hr apart or a single 2 mg i.p injection. To assess
BrdU incorporation, monocytes were stained, fixed, and permeabilized
according to the manufacturer’s instructions prior to analysis by flow cytome-
try. See Supplemental Experimental Procedures for further details.
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Mice were treated with 150 ml of CCR2 mAb (clone: MC21) conditioned media
i.p. To block CD115, mice were treated with CD115 mAb (clone: M279,
MacDonald et al., 2010) i.p. Recombinant M-CSF (PeproTech) (25 mg/mouse)
was given i.p. See Supplemental Experimental Procedures for further details.Histology
Mice were anesthetized and perfused with 30 ml of PBS and organs were
excised and fixed in paraformaldehyde prior to being imbedded in OCT.
Cryostatic sections were post-fixed and stained. Analysis by confocal laser
scanningmicroscopy was performedwith a Zeiss LSM510microscope. Image
acquisition was processed with Zeiss LSM Image browser software. See
Supplemental Experimental Procedures for further details.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
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